SQ-18506 C-14
UNII CR6LN6CY0X

Substance Identification & Data

This profile provides standardized clinical and technical data for Sq-18506 C-14, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CR6LN6CY0X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

CR6LN6CY0X

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SQ-18506 C-14

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C8H6N4O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

RMZNNIOKNRDECR-AKODIVGJSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

138059636

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1([N+]([O-])=O)oc(\[14CH]=C\c2[nH]c(=N)on2)cc1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sq-18506 C-14. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

TRANS-5-AMINO-3(2-(5-NITRO-FURYL)VINYL) (1',2',4)-OXADIAZOLINE, C14

SYS

Technical Codes

SQ-18506 C-14

External Clinical & Regulatory Resources

Previous UNIICR6K9C2NHK

Next UNIICR6OYN7LDN